| scholarly article | Q13442814 |
| P2093 | author name string | Kailin Yang | |
| Liuting Zeng | |||
| Jinwen Ge | |||
| P2860 | cites work | An automated method for finding molecular complexes in large protein interaction networks | Q21284295 |
| Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders | Q24558589 | ||
| TCMSP: a database of systems pharmacology for drug discovery from herbal medicines | Q27703005 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Network pharmacology: the next paradigm in drug discovery | Q28297997 | ||
| Information flow analysis of interactome networks | Q28475566 | ||
| The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases | Q28660703 | ||
| Network medicine: a network-based approach to human disease | Q29547462 | ||
| STRING v10: protein-protein interaction networks, integrated over the tree of life | Q29615545 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin | Q30393827 | ||
| A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. | Q30433214 | ||
| A network pharmacology approach to evaluating the efficacy of chinese medicine using genome-wide transcriptional expression data | Q30640970 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. | Q51139503 | ||
| Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach. | Q51165443 | ||
| Increased oxidative stress from early pregnancy in women who develop preeclampsia. | Q53196491 | ||
| Calcium supplementation during pregnancy: a systematic review of randomised controlled trials | Q57281576 | ||
| Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units | Q61845775 | ||
| The role of the spiral arteries in the pathogenesis of preeclampsia | Q69446253 | ||
| Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia | Q72516832 | ||
| Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: application to prediction of Caco-2 cell permeability | Q75211567 | ||
| Is oxidative stress the link in the two-stage model of pre-eclampsia? | Q78258200 | ||
| Association of maternal KIR and fetal HLA-C genes with the risk of preeclampsia in the Chinese Han population, Long et al | Q85533189 | ||
| Pathogenesis of preeclampsia: Implications of apoptotic markers and oxidative stress | Q86441103 | ||
| Traditional Chinese medicine network pharmacology: theory, methodology and application | Q86982948 | ||
| Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in the plasma and placentae from preeclamptic patients | Q87345859 | ||
| Prediction of 'drug-likeness'. | Q30829130 | ||
| Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension | Q33666742 | ||
| Antiartherosclerotic effects of plant flavonoids | Q33757899 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach | Q33957682 | ||
| Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy | Q34379583 | ||
| Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion | Q34655444 | ||
| Plasma IL-17, IL-35, interferon-γ, SOCS3 and TGF-β levels in pregnant women with preeclampsia, and their relation with severity of disease | Q34657074 | ||
| Recent Insights into the pathogenesis of pre-eclampsia | Q34682287 | ||
| Pharmacological management of hypertension in pregnancy | Q34746979 | ||
| Chinese herbal prescriptions for osteoarthritis in Taiwan: analysis of National Health Insurance dataset | Q35114033 | ||
| Systems pharmacology dissection of the anti-inflammatory mechanism for the medicinal herb Folium eriobotryae | Q35138964 | ||
| Th1/Th2 balance in preeclampsia | Q35190885 | ||
| Decidual natural killer cell receptor expression is altered in pregnancies with impaired vascular remodeling and a higher risk of pre-eclampsia | Q35227748 | ||
| Preeclampsia: recent insights | Q36288757 | ||
| Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis | Q36721468 | ||
| Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade | Q37459545 | ||
| Deep placentation | Q37826560 | ||
| Kaempferol, a potential cytostatic and cure for inflammatory disorders | Q38242153 | ||
| A novel chemometric method for the prediction of human oral bioavailability | Q38323150 | ||
| Kaempferol and inflammation: From chemistry to medicine | Q38486477 | ||
| SMFM Statement: benefit of antihypertensive therapy for mild-to-moderate chronic hypertension during pregnancy remains uncertain | Q38500416 | ||
| Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia | Q40530224 | ||
| Nitric oxide and pregnancy | Q41449537 | ||
| Nitric oxide and shock | Q41481595 | ||
| The herbal medicines Saireito and Boiogito improve the hypertension of pre-eclamptic rats induced by Nomega-Nitro-L-arginine methyl ester | Q42165037 | ||
| The herbal medicine Toki-shakuyaku-san improves the hypertension and intrauterine growth retardation in preeclampsia rats induced by Nomega-nitro-L-arginine methyl ester | Q44769238 | ||
| Risk factors for pre-eclampsia in an Asian population | Q45013645 | ||
| Effect of quercetine and glutathione on the level of superoxide dismutase, catalase, malonyldialdehyde, blood pressure and neonatal outcome in a rat model of pre-eclampsia induced by NG-nitro-L-arginine-methyl ester | Q45226263 | ||
| Tanshinone II-A: new perspectives for old remedies | Q45746307 | ||
| [Treatment of albuminuria in gestational hypertension puerpera in the severe preeclampeia stage by TCM therapy for stasis-removing and diuresis]. | Q45957329 | ||
| Effect of ingredients of Astragalus-Salvia compound on vascular endothelial cell in placenta and vascular endothelial growth factor mRNA expression in trophocyte in pregnant rats with inhibited nitric oxide synthesis | Q46605642 | ||
| Oxidative stress and changes in antioxidative defense system in erythrocytes of preeclampsia in women | Q46811002 | ||
| A network pharmacology approach to determine active ingredients and rationality of herb combinations of Modified-Simiaowan for treatment of gout | Q47425656 | ||
| A clinical study on TCM differentiation of symptoms and signs in pregnancy hypertension syndrome. | Q47813214 | ||
| The herbal medicine Tokishakuyakusan increases fetal blood glucose concentrations and growth hormone levels and improves intrauterine growth retardation induced by N(omega)-nitro-L-arginine methyl ester | Q48089045 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 16849 | |
| P577 | publication date | 2017-12-04 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Uncovering the Pharmacological Mechanism of Astragalus Salvia Compound on Pregnancy-Induced Hypertension Syndrome by a Network Pharmacology Approach | |
| P478 | volume | 7 |
| Q90148460 | Applications of Network Pharmacology in Traditional Chinese Medicine Research |
| Q92638755 | Combining an in silico approach with an animal experiment to investigate the protective effect of troxerutin for treating acute lung injury |
| Q64072211 | Computational prediction and in vitro validation of VEGFR1 as a novel protein target for 2,3,7,8-tetrachlorodibenzo-p-dioxin |
| Q61450535 | Correlation of gestational hypertension with abnormal lipid metabolism, insulin resistance and D-dimer and their clinical significance |
| Q64097708 | Effect of the drug combination of magnesium sulfate and phentolamine on homocysteine and C-reactive protein in the serum of patients with pregnancy-induced hypertension syndrome |
| Q60915315 | Exploring the Mechanism of Danshen against Myelofibrosis by Network Pharmacology and Molecular Docking |
| Q91717812 | Exploring the Pharmacological Mechanism of Quercetin-Resveratrol Combination for Polycystic Ovary Syndrome: A Systematic Pharmacological Strategy-Based Research |
| Q55093753 | Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds. |
| Q92130485 | Study on the Material Basis of Houpo Wenzhong Decoction by HPLC Fingerprint, UHPLC-ESI-LTQ-Orbitrap-MS, and Network Pharmacology |
| Q52597677 | Uncovering the Mechanisms of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation by Focused Network Pharmacology Approach. |
| Q59811770 | Uncovering the mechanism of Maxing Ganshi Decoction on asthma from a systematic perspective: A network pharmacology study |
| Q89547353 | Use of a Systematic Pharmacological Methodology to Explore the Mechanism of Shengmai Powder in Treating Diabetic Cardiomyopathy |
Search more.